Xilio Therapeutics | 424B5: Prospectus
Apr 15 09:04 ET
Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(19.9%)
Apr 5 16:36 ET
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%), etc.
Apr 5 14:54 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Apr 3 18:54 ET
Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Apr 3 18:54 ET
Xilio Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 1 16:29 ET
Xilio Therapeutics | 10-K: Annual report
Apr 1 16:27 ET
Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Apr 1 16:20 ET
Xilio Therapeutics | 8-K: Current report
Mar 28 16:17 ET
Xilio Therapeutics | 8-K: Current report
Mar 28 07:59 ET
Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)
Feb 14 14:19 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund XI, L.P.
Feb 9 16:36 ET
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%), etc.
Feb 6 16:11 ET
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%), etc.
Feb 5 16:05 ET
Xilio Therapeutics | 8-K: Current report
Jan 19 00:00 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund XI, L.P.
Jan 16 00:00 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Frankenfield Christopher James
Jan 3 00:00 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina
Jan 3 00:00 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Kevin M.
Jan 3 00:00 ET
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Russo Rene
Jan 3 00:00 ET
No Data
No Data